Bio-Rad IH 1000 blood screening system
04 August, 2010 byThe IH 1000 blood screening system is a fully automated, high-throughput system designed for the blood transfusion laboratory utilising the industry-accepted gold standard ID-System gel card technology.
Alere Troponin I, Cardio 2 and Cardio 3
04 August, 2010 byAlere International has launched three next-generation products: Troponin I - a single-analyte, improved sensitivity Troponin I (TnI) test, Cardio2 - a two-analyte panel consisting of the new Troponin I and BNP as well as Cardio3 - a three-analyte panel consisting of the new Troponin I, BNP and CK-MB. These improved tests allow for earlier detection of even lower levels of TnI, which improves outcomes and benefits the patient, the hospital, the physician office laboratory and the cardiologist.
Asuragen and Life Technologies BCR/ABL1 Quant Test
04 August, 2010 byAsuragen and Life Technologies have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant Test, Asuragen’s clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukaemia (CML). Asuragen manufactures the monitoring test, which is exclusively distributed by Life Technologies and runs on the company’s Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument.
SeptiCyte Lab sepsis test
04 August, 2010 byMolecular diagnostics company Athlomics, in collaboration with Mater Pathology, has launched an immune system gene expression test for the diagnosis of severe infections, commonly known as sepsis.
R-Biopharm direct detection of C. difficile toxins A and B
04 August, 2010Article No. N0803 is a simple, one-step rapid test based on lateral flow technology that enables direct detection of C. difficile toxins A and B in well homogenised stool samples in 15 minutes. The test kit contains all utensils needed for successful assay performance and allows users to make 25 individual determinations. A positive control, which is not provided with the kit, can be ordered separately under Art. No. NP0804.
Oxoid Australia Xpect Legionella immunochromatographic test
03 June, 2010 byXpect Legionella is a rapid immunochromatographic test for the direct detection of Legionella pneumophila serogroups one and six antigen in human urine samples.
Myco Scan Mycoplasma testing kit
06 April, 2010
by
The Myco Scan Kit can be used to do rapid and reliable Mycoplasma contamination using real-time PCR.
Label-free, cell-based assays using clonetics cell systems and MDS Analytical Technologies’ CellKey System
01 April, 2010Label-free, cell-based assay platforms are innovative tools for assessing the integrated functional responses of cells to drug-like compounds.
BioPlex 2200 anti-CCP assay test
30 March, 2010 byThe BioPlex 2200 anti-CCP test, based on Axis-Shield’s anti-CCP technology, can be used for the early detection of rheumatoid arthritis. The assay measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have good specificity in the diagnosis of rheumatoid arthritis.
PerkinElmer GSP Genetic Screening Processor
04 February, 2010 byPerkinElmer has received 510K clearance from the US Food and Drug Administration for its GSP Genetic Screening Processor, which is used by public health laboratories worldwide as part of newborn screening programs.
Bio-Rad BioPlex 2200 Anti-CCP test
04 February, 2010 byBio-Rad Laboratories and Axis-Shield have launched Bio-Rad’s BioPlex 2200 Anti-CCP test for the early detection of rheumatoid arthritis. The assay, which will run on Bio-Rad’s BioPlex 2200 system, measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have superior specificity in the diagnosis of rheumatoid arthritis. The BioPlex 2200 Anti-CCP kit is based on Axis-Shield’s proprietary anti-CCP technology. The assay is available for sale in certain countries outside the US.
Optical chip detects blood molecules
01 December, 2009A portable ‘lab on a chip’ that can identify target molecules in blood samples has been created by European researchers. It is being used to measure fertility hormones and detect the genes associated with certain types of cancer.
Analytik Jena molecular-genetic rapid pathogen identification
30 November, 2009 byAnalytik Jena has developed a molecular-genetic rapid test for the direct identification of pathogens, validated for its rapid cycler and the standard Biometra cycler.
Bio-Rad acquires Biotest diagnostics
20 November, 2009 byBio-Rad Laboratories has signed an agreement to acquire certain diagnostic businesses of Biotest for 45 million euros, the terms of which were not disclosed. The transaction is subject to closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2010.
Beckman Coulter Access Sex Hormone Binding Globulin (SHBG) assay
20 November, 2009 byBeckman Coulter has expanded its reproductive disease state management range with the Access Sex Hormone Binding Globulin (SHBG) assay for use in the differential diagnosis of conditions of chronic or excessive androgenic activity. The assay may also be used in conjunction with the Access Testosterone Assay to provide a calculated free androgen index1.
